Počet záznamov: 1  

LEOPARD-syndróm

  1. SYSd044542
    LBL
      
    00000nx--j22000003--45--
    005
      
    20240119201433.0
    100
      
    $a 20030709csloy0103----ba0
    152
      
    $b mesh
    250
      
    $a LEOPARD-syndróm $x BL $x CF $x CI $x CL $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo
    300
    1-
    $a 2004; use NEUROFIBROMATOSIS 1 2002 -2003 $8 eng
    300
    1-
    $a Lentigo (1970-2003) $8 eng
    300
    1-
    $a Syndrome (1971-2003) $8 eng
    330
    1-
    $a An autosomal dominant disorder with an acronym of its seven features (LENTIGO; ELECTROCARDIOGRAM abnormalities; ocular HYPERTELORISM; PULMONARY STENOSIS; abnormal genitalia; retardation of growth; and DEAFNESS or SENSORINEURAL HEARING LOSS). This syndrome is caused by mutations of PTPN11 gene encoding the non-receptor PROTEIN TYROSINE PHOSPHATASE, type 11, and is an allelic to NOONAN SYNDROME. Features of LEOPARD syndrome overlap with those of NEUROFIBROMATOSIS 1 which is caused by mutations in the NEUROFIBROMATOSIS 1 GENES. $8 eng
    550
      
    $3 sllk_un_auth*d009456 $Y Neurofibromatosis 1 $5 B $a neurofibromatóza 1
    550
      
    $3 sllk_un_auth*d009634 $Y Noonan Syndrome $5 B $a Noonanovej syndróm
    550
      
    $3 sllk_un_auth*d009456 $Y Neurofibromatosis 1 $5 F $a neurofibromatóza 1
    550
      
    $3 sllk_un_auth*d009634 $Y Noonan Syndrome $5 F $a Noonanovej syndróm
    686
      
    $a C05.660.207.525
    686
      
    $a C14.240.400.695
    686
      
    $a C14.280.400.695
    686
      
    $a C14.280.484.716.525
    686
      
    $a C16.131.077.525
    686
      
    $a C16.131.240.400.685
    686
      
    $a C16.131.621.207.525
    686
      
    $a C17.800.621.430.530.550.525
    750
      
    $a LEOPARD Syndrome $8 eng
    801
    -0
    $a US $b DNLM $c 20030709
    801
    -2
    $a SK $b BA006 $c 20040415
    980
      
    $x M
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.